Utah Medical Products (UTMD)
(Delayed Data from NSDQ)
$56.84 USD
+0.06 (0.11%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $57.16 +0.32 (0.56%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
UTMD 56.84 +0.06(0.11%)
Will UTMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for UTMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UTMD
UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%
Top Analyst Reports for JPMorgan, Novartis & AT&T
UTMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Utah Medical Q1 Earnings Drop 16% on Sales Slump, Stock Up 1%
The Zacks Analyst Blog Highlights Verizon Communications, The Southern Company, Blackstone, Utah Medical Products and The Eastern Company
Top Research Reports for Verizon, The Southern Co. & Blackstone
Other News for UTMD
Utah Medical Products declares $0.305 dividend
Utah Medical Products, Inc. Announces Quarterly Dividend | UTMD Stock News
UTMD Reports Decline in Q2 Revenue Compared to Last Year | UTMD Stock News
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 | UTMD Stock News
Utah Medical Products reports Q2 EPS 94c vs. 98c last year